Related Experiment Video
Updated: Jan 24, 2026
05:25
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
2.9K
CBD: A New Hope?
Paula Morales1, Patricia H Reggio2
1Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid 28006, Spain.
ACS Medicinal Chemistry Letters
|May 18, 2019
Abstract:
The nonpsychoactive phytocannabinoid, CBD, was recently approved by the Food and Drug Administration for the treatment of children with drug-resistant epilepsy. This milestone opens new avenues for cannabinoid research. In this Viewpoint, we provide an overview of recent progress in the field highlighting molecular insights into CBD's mechanism of action, as well as its therapeutic potential.
